Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation
Table 2
Linear regression models of the relation between PCZ serum concentration and treatment group and specific patient factors.